Auxier Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.33M | Sell |
21,851
-49
| -0.2% | -$2.86K | 0.19% | 102 |
|
|
2025
Q4 | $1.18M | Sell |
21,900
-1,840
| -8% | -$88.5K | 0.17% | 105 |
|
|
2025
Q3 | $1.07M | Buy |
23,740
+130
| +0.6% | +$6.07K | 0.15% | 109 |
|
|
2025
Q2 | $1.09M | Sell |
23,610
-92
| -0.4% | -$4.52K | 0.16% | 104 |
|
|
2025
Q1 | $1.45M | Sell |
23,702
-645
| -3% | -$37.6K | 0.22% | 90 |
|
|
2024
Q4 | $1.38M | Sell |
24,347
-150
| -0.6% | -$8.38K | 0.21% | 91 |
|
|
2024
Q3 | $1.27M | Sell |
24,497
-49
| -0.2% | -$2.3K | 0.19% | 94 |
|
|
2024
Q2 | $1.02M | Sell |
24,546
-624
| -2% | -$27.9K | 0.16% | 102 |
|
|
2024
Q1 | $1.36M | Sell |
25,170
-1,604
| -6% | -$81.7K | 0.21% | 94 |
|
|
2023
Q4 | $1.37M | Sell |
26,774
-2,049
| -7% | -$108K | 0.22% | 91 |
|
|
2023
Q3 | $1.67M | Sell |
28,823
-50
| -0.2% | -$3.06K | 0.29% | 80 |
|
|
2023
Q2 | $1.85M | Sell |
28,873
-74
| -0.3% | -$4.96K | 0.31% | 75 |
|
|
2023
Q1 | $2.01M | Sell |
28,947
-300
| -1% | -$21.2K | 0.35% | 74 |
|
|
2022
Q4 | $2.1M | Hold |
29,247
| – | – | 0.36% | 70 |
|
|
2022
Q3 | $2.08M | Sell |
29,247
-849
| -3% | -$61.6K | 0.4% | 66 |
|
|
2022
Q2 | $2.32M | Sell |
30,096
-999
| -3% | -$76.1K | 0.41% | 66 |
|
|
2022
Q1 | $2.27M | Buy |
31,095
+75
| +0.2% | +$5.04K | 0.36% | 73 |
|
|
2021
Q4 | $1.93M | Buy |
31,020
+1
| +0% | +$59 | 0.3% | 80 |
|
|
2021
Q3 | $1.83M | Sell |
31,019
-49
| -0.2% | -$3.23K | 0.31% | 82 |
|
|
2021
Q2 | $2.08M | Sell |
31,068
-539
| -2% | -$35.1K | 0.34% | 79 |
|
|
2021
Q1 | $2M | Sell |
31,607
-402
| -1% | -$25K | 0.34% | 77 |
|
|
2020
Q4 | $1.99M | Buy |
32,009
+14,570
| +84% | +$896K | 0.37% | 73 |
|
|
2020
Q3 | $1.05M | Buy |
17,439
+1,233
| +8% | +$74.2K | 0.22% | 89 |
|
|
2020
Q2 | $953K | Buy |
16,206
+9,181
| +131% | +$549K | 0.21% | 89 |
|
|
2020
Q1 | $392K | Buy |
7,025
+645
| +10% | +$39.4K | 0.1% | 113 |
|
|
2019
Q4 | $410K | Buy |
6,380
+311
| +5% | +$17.8K | 0.08% | 123 |
|
|
2019
Q3 | $308K | Buy |
6,069
+150
| +3% | +$7.05K | 0.06% | 129 |
|
|
2019
Q2 | $268K | Buy |
5,919
+75
| +1% | +$3.49K | 0.05% | 135 |
|
|
2019
Q1 | $279K | Sell |
5,844
-1,200
| -17% | -$59.8K | 0.06% | 130 |
|
|
2018
Q4 | $366K | Sell |
7,044
-225
| -3% | -$12.1K | 0.08% | 120 |
|
|
2018
Q3 | $451K | Hold |
7,269
| – | – | 0.09% | 123 |
|
|
2018
Q2 | $402K | Sell |
7,269
-124
| -2% | -$6.7K | 0.08% | 122 |
|
|
2018
Q1 | $468K | Buy |
7,393
+1,000
| +16% | +$64.3K | 0.09% | 119 |
|
|
2017
Q4 | $392K | Hold |
6,393
| – | – | 0.08% | 125 |
|
|
2017
Q3 | $407K | Hold |
6,393
| – | – | 0.08% | 120 |
|
|
2017
Q2 | $356K | Sell |
6,393
-1,000
| -14% | -$54.4K | 0.07% | 131 |
|
|
2017
Q1 | $402K | Buy |
7,393
+2,700
| +58% | +$148K | 0.08% | 124 |
|
|
2016
Q4 | $274K | Hold |
4,693
| – | – | 0.06% | 135 |
|
|
2016
Q3 | $253K | Sell |
4,693
-300
| -6% | -$19.3K | 0.06% | 136 |
|
|
2016
Q2 | $367K | Hold |
4,993
| – | – | 0.08% | 115 |
|
|
2016
Q1 | $319K | Buy |
4,993
+50
| +1% | +$3.15K | 0.08% | 119 |
|
|
2015
Q4 | $340K | Sell |
4,943
-100
| -2% | -$6.61K | 0.08% | 119 |
|
|
2015
Q3 | $299K | Hold |
5,043
| – | – | 0.07% | 118 |
|
|
2015
Q2 | $336K | Hold |
5,043
| – | – | 0.07% | 115 |
|
|
2015
Q1 | $325K | Hold |
5,043
| – | – | 0.07% | 122 |
|
|
2014
Q4 | $298K | Hold |
5,043
| – | – | 0.06% | 126 |
|
|
2014
Q3 | $258K | Hold |
5,043
| – | – | 0.05% | 133 |
|
|
2014
Q2 | $245K | Sell |
5,043
-739
| -13% | -$36.4K | 0.05% | 134 |
|
|
2014
Q1 | $300K | Hold |
5,782
| – | – | 0.06% | 128 |
|
|
2013
Q4 | $307K | Hold |
5,782
| – | – | 0.06% | 129 |
|
|
2013
Q3 | $268K | Hold |
5,782
| – | – | 0.06% | 129 |
|
|
2013
Q2 | $258K | Buy |
+5,782
| New | +$251K | 0.06% | 127 |
|
Other funds holding BMY
VCM
VPM
Auxier Asset Management's BMY Position: Q1 2026 in Review
Auxier Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.22% in Q1 2026, selling an estimated $2.86K and leaving 21,851 shares worth $1.33M. The position accounts for 0.19% of the portfolio, ranked #102.
Auxier Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.32M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Auxier Asset Management held 21,851 shares of Bristol-Myers Squibb worth $1.33M as of Q1 2026.
- Auxier Asset Management sold 49 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.86K.
- Bristol-Myers Squibb made up 0.19% of Auxier Asset Management's portfolio in Q1 2026, its #102 holding.
- Auxier Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Auxier Asset Management's Bristol-Myers Squibb position peaked at $2.32M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.